Skip to main content

LIAISON® Lyme Disease Diagnostic Solution

Borrelia burgdorferi is among the world’s fastest growing infectious diseases and one of the most difficult to diagnose. If left untreated, the multi-organ tick-borne infection can cause neuropathy, meningitis, cardiac conduction abnormalities, and arthritis. Diasorin is helping prevent these effects with easy, automated and cost-effective serology testing.

LIAISON® XL / LIAISON® XS

LIAISON® Lyme IgG

The LIAISON® Lyme IgG assay uses chemiluminescence immunoassay (CLIA) technology for the  qualitative detection of IgG antibodies to Borrelia burgdorferi in human serum and plasma specimens (K2-EDTA, Li-heparin). The test runs on the LIAISON® analyzer family. 

LIAISON® XL / LIAISON® XS

LIAISON® Lyme IgM

The LIAISON® Lyme IgM assay uses chemiluminescence immunoassay (CLIA) technology for the  qualitative detection of IgM antibodies to Borrelia burgdorferi in human serum and plasma specimens (K2-EDTA, Li-heparin). The test runs on the LIAISON® analyzer family.

LIAISON® XL / LIAISON® XS

LIAISON® Lyme Total Antibody Plus

The LIAISON® Lyme Total Antibody Plus assay uses chemiluminescence immunoassay (CLIA) technology for the qualitative determination of lgG and IgM antibodies of Borrelia burgdorferi in human serum and plasma (K2-EDTA, Li-heparin) samples. The test runs on the LIAISON® analyzer family.

Indications for use

Diagnosis

Suspected Lyme disease, even from an early stage

Target patient

Adults and children exposed to a potential tick bite

Use area

General medicine, public health

Background

Accurate detection means better prognosis

Because the clinical manifestation of Lyme borreliosis can be similar to that of other diseases, and early treatment is crucial in preventing potentially serious health issues, the accurate and early detection of Borrelia infections is a fundamental diagnostic aid.

The LIAISON® Lyme Disease Diagnostic Solution ensures improved diagnostic sensitivity in all stages of a Lyme borreliosis infection – from the first days after a tick bite (LIAISON® LymeDetect®) to weeks, months and years (LIAISON®Borrelia burgdorferi IgG and LIAISON®Borrelia burgdorferi IgM).

How it works

The LIAISON® Lyme assays are based on recombinant proteins that allow reduction of cross-reactivity problems providing higher specificity in comparison with whole-cell lysate assays. The use of immunodominant Borrelia antigens have improved the diagnostic sensitivity in all stages of Lyme infection.

Increases accuracy and help solve diagnostic ambiguities

01

No need for specialized staff

LIAISON® Lyme disease solutions run on the LIAISON® XL and LIAISON® XS chemiluminescence analyzers in any laboratory setting.

02

Fast, automated, reproducible results

LIAISON® Lyme serology solutions (IgG, IgM and Total Antibody) ensure timely results just in a single-step process, the recombinant technologies and the careful manufacturing procedures assure result operator independent.

03

High-quality, ready-to-use CLIA assay

Standardized results, automatic processing and an inclusive and traceable workflow ensures easy integration into any lab routine and virtually eliminates the cumbersome hands-on and subjective reading of traditional Serologic sTTT methods.

Why use it

Why use LIAISON® Lyme Disease Diagnostic Solution

The high diagnostic accuracy of our LIAISON® Lyme Disease Diagnostic Solution helps solve diagnostic ambiguities, mitigating the effect of external factors that can complicate serological findings.

Effective diagnosis

The innovative combination (serology + IGRA technology) of  our LIAISON® Lyme disease solution ensures effective diagnosis within weeks of contact with an infected tick, with concrete benefits for physicians, patients and laboratories.

Fully automated and traceable workflow

Easy integration into daily lab routines, the fully automated solution virtually eliminates the cumbersome hands-on and subjective reading of the current standard of care.

Pioneering, easy-to-use diagnostics

Diasorin’s intuitive, end-to-end process ensures improved turnaround time, optimal cost management and straightforward integration within any laboratory workflow; improving response time without increasing operational costs.

To be used on

Designed for both specialty and routine tests, LIAISON® XL and LIAISON® XS immunoassay analyzers help your laboratory handle multiple patients and tests simultaneously. LIAISON® systems are trustworthy, intuitive and deliver automated continuous operation with minimal user intervention. The result is reduced turnaround time, optimal cost management and unmatched growth potential.

Fully Automated LIAISON® XL System - Diasorin

LIAISON® XL

Designed for large laboratories. Combine the benefits of high throughput and high sensitivity within a powerful and fully automated system that can seamlessly connect to facilitate Total Laboratory Automation. 

Discover more
Fully Automated LIAISON® XS System - Diasorin

LIAISON® XS

A fully automated, easy-to-use benchtop analyzer. Maximize productivity with optimal cost management, no daily maintenance, straightforward integration, and the same capabilities as Diasorin’s high-throughput analyzers. 

Discover more

More details about our diagnostic solutions

Login to Dialog for additional resources

Login to our repository for instructions for use and user manuals, assay information, protocols and much more.

Dialog

Get in touch

If you need any information about our products, contact our specialists. 

Contact us

Need any help?

Get help with Diasorin products and services.

Ask for support

All the products in this family

Discover the range of specialty tests available

Discover more